Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among <i>MSH2</i> mutation carriers

Abstract

Patients with Lynch syndrome carrying an MSH2 mutation are at increased risk of urinary tract cancer including bladder cancer. In these cases surveillance should be considered.